A recent study in which Axl expression was enhanced over that of Tyro3 and Mer showed a modest suppression of cell proliferation in prostate carcinoma cell lines and this reduction could in turn be blocked by ERK1/2 inhibitors [50] a finding that differed from an earlier study [36]. This evidence concerns the gene AXL and prostate carcinoma.